Annual Statements Open main menu

SIGMATRON INTERNATIONAL INC - Quarter Report: 2023 July (Form 10-Q)

sgma-20230731x10q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

Form 10-Q

__________________

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the quarterly period ended July 31, 2023

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-23248

SIGMATRON INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Picture 1

Delaware

36-3918470

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

2201 Landmeier Road

Elk Grove Village, Illinois

60007

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (847) 956-8000

Title of each class

Common Stock $0.01 par value per share

Trading Symbol

SGMA

Name of each exchange on which registered

The NASDAQ Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨



SigmaTron International, Inc.

July 31, 2023

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files. Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of a “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ¨     Accelerated Filer ¨

Non-accelerated Filer x      Smaller Reporting Company x

Emerging Growth Company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ¨ No x

Indicate the number of shares outstanding of the registrant’s common stock, $0.01 par value, as of September 8, 2023: 6,094,288

2


SigmaTron International, Inc.

Index

PART 1.

FINANCIAL INFORMATION:

Page No.

Item 1.

Condensed Consolidated Financial Statements

Condensed Consolidated Balance Sheets – July 31, 2023 (Unaudited) and April 30, 2023

4

Condensed Consolidated Statements of Operations – (Unaudited)

Three Months Ended July 31, 2023 and 2022

6

Condensed Consolidated Statements of Changes in Stockholders’

Equity – (Unaudited) Three Months Ended July 31, 2023 and 2022

7

Condensed Consolidated Statements of Cash Flows – (Unaudited)

Three Months Ended July 31, 2023 and 2022

8

Notes to Condensed Consolidated Financial Statements – (Unaudited)

10

Item 2.

Management’s Discussion and Analysis of Financial Condition and

Results of Operations

35

Item 3.

Quantitative and Qualitative Disclosures About Market Risks

48

Item 4.

Controls and Procedures

PART II

OTHER INFORMATION:

Item 1.

Legal Proceedings

49

Item 1A.

Risk Factors

49

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

49

Item 3.

Defaults Upon Senior Securities

49

Item 4.

Mine Safety Disclosures

49

Item 5.

Other Information

49

Item 6.

Exhibits

50

Signatures

51

 

3


SigmaTron International, Inc.

Condensed Consolidated Balance Sheets

July 31,

2023

April 30,

(Unaudited)

2023

Current assets:

Cash and cash equivalents

$

1,654,891

$

819,129

Accounts receivable, less allowance for credit losses of

$100,000 at July 31, 2023 and April 30, 2023

44,226,653

46,284,818

Inventories, net

158,462,273

165,555,199

Prepaid expenses and other assets

1,736,083

1,678,263

Refundable and prepaid income taxes

411,487

779,705

Other receivables

6,092,331

5,349,328

Total current assets

212,583,718

220,466,442

Property, machinery and equipment, net

35,903,317

35,788,357

Intangible assets, net

1,227,615

1,311,030

Deferred income taxes

2,460,689

2,640,902

Right-of-use assets

6,424,222

7,225,423

Other assets

1,235,547

1,195,045

Total other long-term assets

11,348,073

12,372,400

Total assets

$

259,835,108

$

268,627,199

Liabilities and stockholders' equity:

Current liabilities:

Trade accounts payable

$

74,636,197

$

75,159,716

Accrued wages

8,654,795

7,917,266

Accrued expenses

3,084,368

2,933,430

Income taxes payable

-

1,041,998

Deferred revenue

5,542,269

8,063,197

Current portion of long-term debt

46,980,450

52,761,520

Current portion of finance lease obligations

1,821,641

1,523,259

Current portion of operating lease obligations

2,740,678

2,908,213

Total current liabilities

143,460,398

152,308,599

Long-term debt, less current portion

40,572,777

40,539,180

Income taxes payable

148,888

267,998

Finance lease obligations, less current portion

2,902,042

2,596,178

Operating lease obligations, less current portion

4,111,504

4,723,867

Other long-term liabilities

101,556

100,350

Total long-term liabilities

47,836,767

48,227,573

Total liabilities

191,297,165

200,536,172

4


SigmaTron International, Inc.

Condensed Consolidated Balance Sheets - Continued

July 31,

2023

April 30,

(Unaudited)

2023

Commitments and contingencies

 

 

Stockholders' equity:

Preferred stock, $0.01 par value; 500,000 shares

authorized, none issued or outstanding

-

-

Common stock, $0.01 par value; 12,000,000 shares

authorized, 6,091,288 shares issued and

outstanding at July 31, 2023 and April 30, 2023

60,634

60,634

Capital in excess of par value

42,171,387

41,986,570

Retained earnings

26,305,922

26,043,823

Total stockholders' equity

68,537,943

68,091,027

Total liabilities and stockholders' equity

$

259,835,108

$

268,627,199

The accompanying notes to the condensed consolidated financial statements are an integral part of these statements.


5


SigmaTron International, Inc.

Condensed Consolidated Statements of Operations

Three Months

Three Months

Ended

Ended

July 31,

July 31,

2023

2022

(Unaudited)

(Unaudited)

Net sales

$

98,130,356

$

105,189,979

Cost of products sold

88,479,136

93,612,759

Gross profit

9,651,220

11,577,220

Selling and administrative expenses

6,842,805

6,529,842

Operating income

2,808,415

5,047,378

Other income

18,627

35,816

Interest expense, net

(2,719,078)

(953,558)

Income from continuing operations before income tax expense

107,964

4,129,636

Income tax benefit (expense)

154,135

(1,008,296)

Net income from continuing operations

$

262,099

$

3,121,340

Discontinued operations:

Loss before tax from discontinued operations

-

(2,223,561)

Tax benefit from discontinued operations

-

478,896

Net loss from discontinued operations

$

-

$

(1,744,665)

Net income

$

262,099

$

1,376,675

Basic earnings (loss) per common share:

Income (loss) from continuing operations

0.04

0.52

Income (loss) from discontinued operations

-

(0.29)

Basic earnings (loss) per common share:

$

0.04

$

0.23

Diluted earnings (loss) per common share:

Income (loss) from continuing operations

0.04

0.50

Income (loss) from discontinued operations

-

(0.28)

Diluted earnings (loss) per common share:

$

0.04

$

0.22

Weighted average shares of common stock outstanding

Basic

6,091,288

6,058,908

Weighted average shares of common stock outstanding

Diluted

6,100,284

6,191,395

The accompanying notes to the condensed consolidated financial statements are an integral part of these statements.

6


SigmaTron International, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

For the three months ended July 31, 2023 (Unaudited)

Capital in

Total

Preferred

Common

excess of par

Retained

stockholders’

stock

stock

value

earnings

equity

Balance at May 1, 2023

$

-

$

60,634

$

41,986,570

$

26,043,823

$

68,091,027

Recognition of stock-based
compensation

-

-

184,817

-

184,817

Net income

-

-

-

262,099

262,099

Balance at July 31, 2023

$

-

$

60,634

$

42,171,387

$

26,305,922

$

68,537,943

For the three months ended July 31, 2022 (Unaudited)

Capital in

Total

Preferred

Common

excess of par

Retained

stockholders’

stock

stock

value

earnings

equity

Balance at May 1, 2022

$

-

$

60,379

$

41,654,410

$

46,619,208

$

88,333,997

Recognition of stock-based
compensation

-

-

94,893

-

94,893

Restricted stock awards

-

55

49,818

-

49,873

Net loss from discontinued
operations

-

-

-

(1,744,665)

(1,744,665)

Net income from continuing
operations

-

-

-

3,121,340

3,121,340

Balance at July 31, 2022

$

-

$

60,434

$

41,799,121

$

47,995,883

$

89,855,438


7


SigmaTron International, Inc.

Condensed Consolidated Statements of Cash Flows

Three

Three

Months Ended

Months Ended

July 31,

July 31,

2023

2022

(Unaudited)

(Unaudited)

Cash flows from operating activities

Net income from continuing operations

$

262,099

$

3,121,340

Net loss from discontinued operations

-

(1,744,665)

Adjustments to reconcile net income to net cash provided by

(used in) operating activities from continuing operations:

Depreciation and amortization of property, machinery and equipment

1,496,034

1,457,220

Stock-based compensation

184,817

94,893

Restricted stock expense

-

49,873

Deferred income tax expense

180,213

110,324

Amortization of intangible assets

83,415

85,248

Amortization of financing fees

116,745

79,520

Loss from disposal or sale of machinery and equipment

43,286

13,576

Changes in operating assets and liabilities

Accounts receivable

2,058,165

(10,837,157)

Inventories

7,092,926

(11,397,902)

Prepaid expenses and other assets

189,396

892,516

Refundable and prepaid income taxes

368,218

(77,448)

Income taxes payable

(1,161,108)

209,040

Trade accounts payable

(523,519)

(1,023,788)

Operating lease liabilities

(779,898)

(768,542)

Accrued expenses and wages

660,153

(1,763,440)

Deferred revenue

(2,520,928)

3,085,492

Net cash provided by (used in) operating activities from continuing
operations

7,750,014

(16,669,235)

Cash flows from investing activities from continuing operations

Purchases of machinery and equipment

(621,929)

(313,934)

Net cash used in investing activities from continuing operations

(621,929)

(313,934)

8


SigmaTron International, Inc.

Condensed Consolidated Statements of Cash Flows - Continued

Three

Three

Months Ended

Months Ended

July 31,

July 31,

2023

2022

(Unaudited)

(Unaudited)

Cash flows from financing activities from continuing operations

Proceeds under equipment notes

783,461

-

Payments under finance lease agreements

(428,105)

(353,258)

Payments under equipment notes

(278,250)

(278,138)

Payments under building notes payable

(12,372)

(6,006,127)

Borrowings under term loan agreement

-

40,000,000

Payments under term loan agreement

(250,000)

-

Borrowings under revolving line of credit

103,905,204

123,016,860

Payments under revolving line of credit

(109,632,319)

(135,200,692)

Payments of debt financing costs

(379,942)

(1,290,907)

Net cash (used in) provided by financing activities from continuing
operations

(6,292,323)

19,887,738

Cash flows from discontinued operations:

Net cash used in operating activities

-

(1,457,558)

Net cash used in financing activities

-

(55,481)

Net cash used in discontinued operations

-

(1,513,039)

Change in cash and cash equivalents

835,762

1,391,530

Cash and cash equivalents at beginning of period

819,129

3,054,643

Cash and cash equivalents at end of period

$

1,654,891

$

4,446,173

Supplementary disclosures of cash flow information

Cash paid for interest

$

2,583,509

$

792,971

Cash paid for income taxes

434,038

242,633

Purchase of machinery and equipment financed

under finance leases

1,032,351

825,826

Right-of-use assets obtained in exchange for operating

lease liabilities

1,531

756,380

Financing of insurance policy

229,520

99,768

The accompanying notes to the condensed consolidated financial statements are an integral part of these statements.

 

9


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note A - Description of the Business

SigmaTron International, Inc., its subsidiaries, foreign enterprises and international procurement office (collectively, the “Company”) operates as an independent provider of electronic manufacturing services (“EMS”). The EMS segment includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, the EMS segment also provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. Until the sale described below, effective April 1, 2023, the Company, through its subsidiary, Wagz, Inc. (“Wagz”), operated in a second reportable segment, as a provider of products to the pet technology (“Pet Tech”) market. The Pet Tech reportable segment offered electronic products such as the Freedom Smart Dog Collar™, a wireless geo-mapped fence and wellness system, along with apparel and accessories.

During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into a Stock Purchase Agreement (“SPA”) by and among the Company, Wagz, Vynetic LLC, a Delaware limited liability company (“Buyer”), and Terry B. Anderton, co-founder of Wagz and principal of Buyer (“Anderton”), pursuant to which the Company sold to Buyer 81% of the issued and outstanding shares of common stock of Wagz for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a $900,000 working capital term loan (the “Wagz Loan”) to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated effective as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19% ownership of Wagz common stock and Buyer holds a majority 81% of Wagz common stock.

Note B - Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of SigmaTron International, Inc. (“SigmaTron”), its wholly-owned subsidiaries, Standard Components de Mexico, S.A., AbleMex S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co. Ltd., and Wujiang SigmaTron Electronic Technology Co., Ltd. (collectively, “SigmaTron China”), its international procurement office, SigmaTron International Inc. Taiwan Branch, and Wagz, Inc. (19% ownership, effective as of April 1, 2023), have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.

The accompanying unaudited condensed consolidated financial statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three month period ended July 31, 2023 are not necessarily indicative of the results that may be expected for the year ending April 30, 2024. The condensed consolidated balance

10


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note B - Basis of Presentation - Continued

sheet at April 30, 2023, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. For further information, refer to the condensed consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2023.

On April 1, 2023, SigmaTron completed the sale of a majority interest in the Wagz, Inc. business. In accordance with the authoritative guidance for discontinued operations (Accounting Standards Codification (ASC) 205-20), the Company determined that the Wagz business met discontinued operations accounting criteria at the end of the fourth quarter of fiscal year 2023. The results of the Wagz business and the related cash flows have been reported as discontinued operations in the Consolidated Statements of Operations and Consolidated Statements of Cash Flows, respectively, through the date of sale. These changes have been applied to all periods presented. See Note M - Discontinued Operations, for additional information.

 

Note C - Inventories, net

The components of inventory consist of the following:

July 31,

April 30,

2023

2023

Finished products

$

18,904,503

$

22,093,018

Work-in-process

5,739,599

5,415,917

Raw materials

137,785,867

142,612,325

162,429,969

170,121,260

Less excess and obsolescence reserve

(3,967,696)

(4,566,061)

$

158,462,273

$

165,555,199

 

11


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note D - Earnings Per Share and Stockholders’ Equity

The following table sets forth the computation of basic and diluted (loss) earnings per share:

Three Months Ended

July 31,

July 31,

2023

2022

Net income from continuing operations

$

262,099

$

3,121,340

Net loss from discontinued operations

-

(1,744,665)

Total net income

262,099

1,376,675

Weighted-average shares

Basic

6,091,288

6,058,908

Effect of dilutive stock options

8,996

132,487

Diluted

6,100,284

6,191,395

Basic (loss) earnings per common share

Basic earnings per share from continuing operations

0.04

0.52

Basic loss per share from discontinued operations

-

(0.29)

Basic total earnings per share

$

0.04

$

0.23

Diluted (loss) earnings per common share

Diluted earnings per share from continuing operations

0.04

0.50

Diluted loss per share from discontinued operations

-

(0.28)

Diluted total earnings per share

$

0.04

$

0.22

Options to purchase 602,081 and 508,519 shares of common stock were outstanding and exercisable at July 31, 2023 and 2022, respectively. There were 186,000 options granted during the three month period ended July 31, 2023 and there were no options granted during the three month period ended July 31, 2022. There was $184,817 and $94,893 stock option expense recognized for the three month periods ended July 31, 2023 and 2022, respectively. The balance of unrecognized compensation expense related to the Company’s stock option plans at July 31, 2023 and 2022 was $530,502 and $1,034,531, respectively. There were 379,493 anti-dilutive common stock equivalents and no anti-dilutive common stock equivalents for the three month periods ended July 31, 2023 and 2022, respectively, which have been excluded from the calculation of diluted earnings per share.

12


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note E - Long-term Debt

Debt and finance lease obligations consisted of the following at July 31, 2023 and April 30, 2023:

July 31,

April 30,

2023

2023

Debt:

Notes Payable - Secured lenders

$

84,990,885

$

90,968,000

Notes Payable - Buildings

404,771

417,143

Notes Payable - Equipment

4,029,326

3,524,115

Unamortized deferred financing costs

(1,871,755)

(1,608,558)

Total debt

87,553,227

93,300,700

Less current maturities*

46,980,450

52,761,520

Long-term debt

$

40,572,777

$

40,539,180

Finance lease obligations

$

4,723,683

$

4,119,437

Less current maturities

1,821,641

1,523,259

Total finance lease obligations, less current portion

$

2,902,042

$

2,596,178

* Due to availability being less than 10% of the Revolving Commitment, the Facility (as defined below) has been classified as a current liability on the Consolidated Balance Sheet at July 31, 2023 and April 30, 2023.

Notes Payable – Secured lenders

On January 29, 2021, the Company entered into a Credit Agreement (the “JPM Agreement”) with JPMorgan Chase Bank, N.A. (“Lender” or “JPM”), pursuant to which Lender provided the Company with a secured credit facility consisting of a revolving loan facility and a term loan facility (collectively, the “Facility”).

On July 18, 2022, SigmaTron, Wagz and Lender amended and restated the JPM Agreement by entering into an Amended and Restated Credit Agreement (as so amended and restated, the “JPM Credit Agreement”). The Facility, as amended, allows the Company to borrow on a revolving basis up to the lesser of (i) $70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender (the “Revolving Commitment”). The maturity date of the Facility is July 18, 2027. Deferred financing costs of $238,576 and $332,139 were capitalized during the three month period ended July 31, 2023 and during the fiscal year ended April 30, 2023, respectively, which are amortized over the term of the JPM Credit Agreement. As of July 31, 2023, there was $45,407,584 outstanding and $12,468,259 of unused availability under the revolving loan facility compared to an outstanding balance of $51,134,699 and $11,539,183 of unused availability at April 30, 2023. As of July 31, 2023 and April 30, 2023, the unamortized amount offset against outstanding debt was $763,478 and $572,191, respectively.

13


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note E - Long-term Debt - Continued

Under the JPM Credit Agreement, a minimum Fixed Charge Coverage Ratio (“FCCR”) financial covenant of 1.10x is applicable only during an FCCR trigger period which occurs when (a) commencing on the Effective Date (as defined in the JPM Credit Agreement) and ending when the Term Loan Obligations (as defined in the JPM Credit Agreement) have been paid in full and (b) following the payment in full of the Term Loan Obligations, (i) an event of default (as defined in the JPM Credit Agreement) has occurred and is continuing, and Lender has elected to impose a FCCR trigger period upon notice to the Company or (ii) availability falls below the greater of (y) 10% of the Revolving Commitment and (z) the outstanding principal amount of the term loans. In addition, prior to the amendment to the JPM Credit Agreement pursuant to the JPM Waiver (as discussed below under “Waiver, Consent and Amendment to Credit Agreements”), the JPM Credit Agreement imposed a financial covenant that required the Company to maintain a leverage ratio of Total Debt to EBITDA (each as defined in the JPM Credit Agreement) for any twelve month period ending on the last day of a fiscal quarter through the maturity of the revolving Facility not to exceed a certain amount, which ratio (a) ranged from 5.00-to-1 for fiscal quarters beginning with the fiscal quarter ending on January 31, 2023 to 3.00-to-1 for the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio (as defined in the JPM Credit Agreement) as of the end of the applicable fiscal quarter is less than or equal to 1.50-to-1) and (b) ranged from 5.50-to-1 for the fiscal quarter ending on January 31, 2023 to 4.00-to-1 for the fiscal quarters beginning with the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio as of the end of the applicable fiscal quarter is greater than 1.50-to-1).

In addition, the JPM Credit Agreement imposes a cash dominion period if there is an event of default or if availability is less than 10% of the Revolving Commitment, and such requirement continues until there is no event of default and availability is greater than 10% of the Revolving Commitment, in each case for 30 consecutive days. Based on this criteria, the total debt balances for the Facility must be classified as a current liability on the Consolidated Balance Sheet as of July 31, 2023 and April 30, 2023.

In connection with the entry into the JPM Credit Agreement, Lender and TCW Asset Management Company LLC, as administrative agent under the Term Loan Agreement (as defined below), entered into the Intercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”), to set forth and govern the lenders’ respective lien priorities, rights and remedies under the JPM Credit Agreement and the Term Loan Agreement.

The Facility under the JPM Credit Agreement is secured by: (a) a first priority security interest in SigmaTron’s and Wagz’s (i) accounts receivable and inventory (excluding Term Priority Mexican Inventory (as defined in the ICA) and certain inventory in transit, (ii) deposit accounts, (iii) proceeds of business interruption insurance that constitute ABL BI Insurance Share (as defined in the ICA), (iv) certain other property, including payment intangibles, instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all proceeds of the foregoing, in each case, now owned or hereafter acquired (collectively, the “ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) the equity interests of SigmaTron’s foreign subsidiaries (unless such a pledge is requested by Lender).

14


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note E - Long-term Debt - Continued

On July 18, 2022, SigmaTron, Wagz and TCW Asset Management Company LLC, as administrative agent (the “Agent”), and other Lenders party thereto (collectively, the “TCW Lenders” and together with the Agent, “TCW”) entered into a Credit Agreement (the “Term Loan Agreement”) pursuant to which TCW made a term loan to the Company in the principal amount of $40,000,000 (the “TCW Term Loan”). The TCW Term Loan bears interest at a rate per annum based on SOFR, plus the Applicable Margin of 7.50% (each as defined in the Term Loan Agreement). The TCW Term Loan has a SOFR floor of 1.00%. The maturity date of the TCW Term Loan is July 18, 2027. The amount outstanding as of July 31, 2023, was $39,583,301 compared to an outstanding balance of $39,833,301 at April 30, 2023. Deferred financing costs of $141,366 and $1,233,894 were capitalized during the three month period ended July 31, 2023 and fiscal year ended April 30, 2023, respectively. As of July 31, 2023 and April 30, 2023, the unamortized amount offset against outstanding debt was $1,108,277 and $1,036,367, respectively.

The Term Loan Agreement imposes financial covenants, including covenants requiring the Company to maintain a minimum Fixed Charge Coverage Ratio (as defined in the Term Loan Agreement) of 1.10-to-1 and maintain the same leverage ratio of Total Debt to EBITDA as described above under the JPM Credit Agreement. The Company is required to make quarterly repayments of the principal amount of the TCW Term Loan in amounts equal to $250,000 per fiscal quarter for the quarters beginning October 31, 2022 and $500,000 per fiscal quarter for quarters beginning October 31, 2024. The Term Loan Agreement also requires mandatory annual repayments equal to 50% of Excess Cash Flow (as defined in the Term Loan Agreement).

The TCW Term Loan is secured by: (a) a first priority security interest in all property of SigmaTron and Wagz that does not constitute ABL Priority Collateral, which includes: (i) SigmaTron’s and Wagz’s real estate other than SigmaTron’s Del Rio, Texas, warehouses, (ii) SigmaTron’s and Wagz’s machinery, equipment and fixtures (but excluding ABL Priority Equipment (as defined in the ICA)), (iii) the Term Priority Mexican Inventory (as defined in the ICA), (iv) SigmaTron’s stock in its direct and indirect subsidiaries, (v) SigmaTron’s and Wagz’s general intangibles (excluding any that constitute ABL Priority Collateral), goodwill and intellectual property, (vi) the proceeds of business interruption insurance that constitute Term BI Insurance Share (as defined in the ICA), (vii) tax refunds, and (viii) all proceeds thereof, in each case, now owned or hereafter acquired (collectively, the “Term Priority Collateral”); and (b) a second priority security interest in all collateral that constitutes ABL Priority Collateral. Also, SigmaTron’s three Mexican subsidiaries pledged all of their assets as security for the TCW Term Loan.

15


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note E - Long-term Debt - Continued

Waiver, Consent and Amendment to Credit Agreements

On March 2, 2023, the Company received notices of default from both JPM and TCW. The Notices indicated the occurrence of certain events of default under the JPM Credit Agreement and the Term Loan Agreement (together with the JPM Credit Agreement the “Credit Agreements”). In addition, the Company received a delinquency notification letter from Nasdaq indicating that the Company was not in compliance with the continued listing requirements of Nasdaq for failing to timely file the Companys Form 10-Q for the fiscal quarter ended January 31, 2023. This notification also constituted a default under the Credit Agreements. The delinquency was remedied on May 19, 2023.

The JPM Notice indicated that the Lender was informed of the occurrence of events of defaults and the continuation thereof under the JPM Credit Agreement as a result of the Company’s failure to maintain a FCCR for the twelve month period ended January 31, 2023 of at least 1.10x as required under the JPM Credit Agreement (the “JPM Covenant Defaults”).

The TCW Notice indicated that Agent and TCW Lenders were informed of the occurrence of events of default and the continuation thereof under the Term Loan Agreement (described below) as a result of the Company permitting the Total Debt to EBITDA Ratio for the twelve month period ended on January 31, 2023 to be greater than 5.00:1.00 in violation of the Term Loan Agreement and the Company’s failure to maintain FCCR as required under the JPM Credit Agreement (the “TCW Covenant Defaults” and together with the JPM Covenant Defaults, the “Defaults”).

As a result of the Defaults, the Company was not in compliance with its financial covenants under the Credit Agreements as of January 31, 2023. Due to the Notices received on March 2, 2023, from each of JPM and TCW, the total debt balances for both the Facility and the TCW Term Loan had been classified as a current liability on the Condensed Consolidated Balance Sheet as of January 31, 2023.

On April 28, 2023, the Company entered into (i) a Waiver, Consent and Amendment No. 1 to the JPM Credit Agreement (“JPM Waiver”) with Wagz and JPM, as lender, which waived certain events of default under and amended certain terms of the JPM Credit Agreement and (ii) a Waiver, Consent and Amendment No. 1 to the Credit Agreement (“TCW Waiver”) with Wagz and TCW (collectively with JPM, the “Lender Parties”), which waived certain events of default under and amended certain terms of the Credit Agreements. The Company was in compliance with its revised financial covenants under the Credit Agreements as of July 31, 2023.

Pursuant to the Waivers, the Company has agreed, among other things, to (i) if requested by the Agent, effect a corporate restructuring that would create a new holding company structure to own all of the Companys stock through a merger pursuant to Section 251(g) of the General Corporation Law of the State of Delaware, after which the holding company would continue as the public company,

16


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note E - Long-term Debt - Continued

become a guarantor under the Credit Agreements and pledge to the Lender Parties all of the equity of the Company (the “Corporate Restructuring”), (ii) engage a financial advisor to review certain of the Companys financial reporting to JPM and the Agent and participate in weekly conference calls with the advisor, JPM and the Agent to discuss and provide updates on the Companys liquidity and operations, (iii) extend the Wagz Loan, (iv) pay to JPM an amendment fee in the amount of $70,000, paid in cash, and (v) pay to the TCW Lenders an amendment fee of $395,000 and a default rate fee of $188,301, both of which were paid in kind by being added to the principal of the TCW Term Loan.

The Waivers also amended the Credit Agreements to, among other things, (x) require that the Company maintain a minimum of $2.5 million in revolver availability under the JPM Credit Agreement, (y) modify the definition of EBITDA to allow adjustments to account for Wagz operating losses, impairment charges relating to the write-down of the Wagz business, the Wagz Loan and net assets of the Company and Wagz, and expenses relating to the Waivers, the Wagz sale and SPA, and (z) modify the existing Total Debt to EBITDA Ratios (as defined in the Credit Agreements) as follows:

Fiscal Quarter

Total Debt to EBITDA Ratio* (as amended)

Total Debt to EBITDA Ratio* (prior to amendment)

October 31,2023

4.50:1.0

4.25:1.0

January 31, 2024

4.50:1.0

4.00:1.0

April 30, 2024

4.50:1.0

4.00:1.0

July 31, 2024

4.25:1.0

3.75:1.0

October 31, 2024

4.00:1.0

3.75:1.0

* Assumes the Term Loan Borrowing Base Coverage Ratio (as defined in the Credit Agreements) is less than or equal to 1.50:1.0.

In addition, pursuant to the TCW Waiver, if the Total Debt to EBITDA Ratio for the trailing twelve month period as of the end of the third quarter of fiscal 2023 exceeds the ratios that were in effect prior to the amendment (as set forth in the far right column of the table above) for a fiscal quarter during the PIK Period (defined in the Term Loan Agreement), then the Applicable Margin under the Term Loan Agreement in respect of the outstanding TCW Term Loan would increase by an amount equal to 1.0% per annum for the fiscal quarter, with such interest being paid in kind. Furthermore, the JPM Waiver modified the definition of Applicable Margin from a fixed amount equal to 2.00% to an amount that varies from 2.00% (for revolver availability greater than or equal to $20.0 million), to 2.50% (for revolver availability greater than or equal to $10.0 million), to 3.00% (for revolver availability less than $10.0 million), and fixed the Applicable Margin at 3.00% for six months starting April 1, 2023. The Company was in compliance with its revised financial covenants under the Credit Agreements as of July 31, 2023.

In exchange for such agreements, the Lender Parties waived all of the existing events of default under the Credit Agreements through March 31, 2023, consented to the sale of Wagz and

17


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note E - Long-term Debt - Continued

released Wagz and its property and the Companys 81% interest in Wagz that was sold to Buyer (as disclosed below) from the lien of the Lender Parties.

In connection with the Waivers, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023.

On June 15, 2023, the Company entered into (i) Amendment No. 2 to the Credit Agreement (the “JPM Amendment No. 2”) by and among the Company and Lender, with respect to the JPM Credit Agreement and (ii) Amendment No. 2 to the Credit Agreement (“TCW Amendment No. 2”) by and among the Company and TCW with respect to the Term Loan Agreement. The JPM Amendment No. 2 and TCW Amendment No. 2 (together, the “Amendments”) amended the Credit Agreements to extend the date, from May 31, 2023 to July 31, 2023, after which the Agent may request that the Company effect the Corporate Restructuring.

On March 15, 2019, the Company’s wholly-owned foreign enterprise, Wujiang SigmaTron Electronic Technology Co., Ltd., entered into a credit facility with China Construction Bank. On January 26, 2021, the agreement was amended and expired in accordance with its terms on January 6, 2022. On January 17, 2022, the agreement was renewed, and expired in accordance with its terms on December 23, 2022. On February 17, 2023, the agreement was renewed, and is scheduled to expire on February 7, 2024. Under the agreement Wujiang SigmaTron Electronic Technology Co., Ltd. can borrow up to 10,000,000 Renminbi, approximately $1,400,000 as of July 31, 2023, and the facility is collateralized by Wujiang SigmaTron Electronics Co., Ltd.’s manufacturing building. Interest is payable monthly and the facility bears a fixed interest rate of 3.35% per annum. There was no outstanding balance under the facility at July 31, 2023 and April 30, 2023.

Notes Payable – Buildings

The Company entered into a mortgage agreement on March 3, 2020, in the amount of $556,000, with The Bank and Trust SSB to finance the purchase of the property that serves as the Company’s warehousing and distribution center in Del Rio, Texas. The note requires the Company to pay monthly installment payments in the amount of $6,103. Interest accrues at a fixed rate of 5.75% per year until March 3, 2025, and adjusts thereafter, on an annual basis, equal to 1.0% over the Prime Rate as published by The Wall Street Journal. The note is payable over a 120 month period. The outstanding balance was $404,771 and $417,143 at July 31, 2023 and April 30, 2023, respectively.

18


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note E - Long-term Debt - Continued

Notes Payable – Equipment

The Company routinely entered into secured note agreements with Engencap Fin S.A. DE C.V. to finance the purchase of equipment. The terms of the outstanding secured note agreement, which had a fixed interest rate of 8.00% per annum, matured on May 1, 2023, with a final quarterly installment payment of $9,310.

The Company routinely enters into secured note agreements with FGI Equipment Finance LLC to finance the purchase of equipment. The terms of the outstanding secured note agreements mature from March 2025 through August 2028, with quarterly installment payments ranging from $10,723 to $69,439 and a fixed interest rate ranging from 8.25% to 11.75% per annum.

Annual maturities of the Company’s debt, net of deferred financing fees for the remaining periods, as of July 31, 2023, are as follows:

Secured lenders

Building

Equipment

Total

For the remaining 9 months of the fiscal year ending April 30:

2024

$

45,394,106

$

38,199

$

900,945

$

46,333,250

For the fiscal years ending April 30:

2025

1,467,036

53,557

1,335,736

2,856,329

2026

1,717,036

56,719

987,526

2,761,281

2027

1,717,036

60,068

454,913

2,232,017

2028

32,823,916

63,614

249,932

33,137,462

2029

-

132,614

100,274

232,888

$

83,119,130

$

404,771

$

4,029,326

$

87,553,227

* Due to availability being less than 10% of the Revolving Commitment, the Facility (as defined above) has been classified as a current liability on the Consolidated Balance Sheet at July 31, 2023. The maturity date of both the Facility and the TCW Term Loan is July 18, 2027 with an outstanding balance of $83,119,130.

Finance Lease Obligations

The Company enters into various finance lease agreements. The terms of the outstanding lease agreements mature through April 1, 2027, with monthly installment payments ranging from $2,874 to $33,706 and a fixed interest rate ranging from 7.09% to 12.73% per annum.

19


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note F - Income Tax

The income tax benefit was $154,135 for the three month period ended July 31, 2023 compared to an income tax expense of $1,008,296 for the same period in the prior fiscal year. The Company’s effective tax rate was -142.76% and 24.42% for the quarters ended July 31, 2023 and 2022, respectively. The decrease in income tax expense for the three month period ended July 31, 2023 compared to the same period in the previous year is due to decreased taxable earnings in the current quarter compared to the same period in the previous year. The decrease in effective tax rate is due to variations in income earned by jurisdiction.

SigmaTron and Wagz filed or are expected to file U.S. tax returns on a consolidated basis for periods during which Wagz was wholly owned. Therefore, a valuation allowance was previously established on the group’s U.S. deferred tax assets during fiscal year 2022. After the sale of the majority interest in Wagz, SigmaTron expects to file on a standalone basis and utilize its U.S. deferred tax assets with the exception of the capital loss on sale, its investment in subsidiary, and certain foreign tax credits. The Company has established a valuation allowance of $7,258,454 on its U.S. capital loss, its investment in subsidiary, and foreign tax credit carryforwards. The Company has also established a valuation allowance of $284,968 on NOLs attributable to its Vietnam subsidiary as of July 31, 2023. Based on historical losses and forecasted future earnings, the Company has determined that the tax benefit from such assets are not more likely than not to be realized. The Company’s valuation allowance was $7,543,422 and $7,703,517 as of July 31, 2023 and April 30, 2023, respectively.

The Company has not changed its plans to indefinitely reinvest the earnings of the Company’s foreign subsidiaries. The cumulative amount of unremitted earnings for which U.S. income taxes have not been recorded is $13,878,000 as of July 31, 2023.

Note G - Commitments and Contingencies

From time to time the Company is involved in legal proceedings, claims or investigations that are incidental to the conduct of the Company’s business. In future periods, the Company could be subjected to cash cost or non-cash charges to earnings if any of these matters is resolved on unfavorable terms. However, although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including management’s assessment of the merits of any particular claim, the Company does not expect that these legal proceedings or claims will have any material adverse impact on its future consolidated financial position, results of operations or cash flows.

20


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note H - Significant Accounting Policies

Management Estimates and Uncertainties - The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for credit losses, excess and obsolete reserves for inventory, deferred income, deferred taxes, uncertain tax positions, valuation allowance for deferred taxes and valuation of goodwill and long-lived assets. Actual results could materially differ from these estimates.

The potential impact of future disruptions and continued economic uncertainty over public health crises, including COVID-19 and variants, and the global supply chain may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders. It is possible that these potential adverse impacts may result in the recognition of material impairments of the Company’s long-lived assets or other related charges in future periods.

Accounts Receivable - Accounts receivable is presented net of allowance for credit losses of $100,000 as of July 31, 2023 and April 30, 2023. The Company believes that its allowance for credit losses is adequate and represents its best estimate as of July 31, 2023. The Company continues to closely monitor customer liquidity along with industry and economic conditions, which may result in changes to its estimate.

Revenue Recognition - The following table presents the Company’s revenue disaggregated by the principal end-user markets it serves:

Three Months Ended

July 31,

July 31,

Net trade sales by end-market

2023

2022

Industrial Electronics

$

67,875,530 

$

70,329,487 

Consumer Electronics

22,657,886 

28,515,328 

Medical / Life Sciences

7,596,940 

6,345,164 

Total Net Trade Sales

$

98,130,356 

$

105,189,979 

During the three month period ended July 31, 2023, no material revenues were recognized from performance obligations satisfied or partially satisfied in previous periods and no amounts were allocated to performance obligations that remain unsatisfied or partially unsatisfied at July 31, 2023. The Company is electing not to disclose the amount of the remaining unsatisfied performance obligations with a duration of one year or less. The Company had no material remaining unsatisfied performance obligations as of July 31, 2023, with an expected duration of greater than one year.

21


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note H - Significant Accounting Policies - Continued

Contract liabilities consist of payments received in advance of the transfer of control to the customer. As products are delivered and control transfers, the Company recognizes the deferred revenue in net sales in the Consolidated Statements of Operations. The following table summarizes the deferred revenue associated with payments received in advance of the transfer of control to the customer reported as deferred revenue in the Consolidated Balance Sheets and amounts recognized through net sales for each period presented.

Three Months Ended

July 31,

July 31,

2023

2022

Contract liability (deferred revenue) beginning of period

$

8,063,197 

$

11,394,820 

Deferred revenue recognized in period

(4,996,715)

(13,384,902)

Revenue deferred in period

2,475,787 

16,470,394 

Deferred revenue end of period

$

5,542,269 

$

14,480,312 

Income Tax - The Company’s income tax expense, deferred tax assets and liabilities and reserves for unrecognized tax benefits reflect management’s best assessment of estimated future taxes to be paid. The Company is subject to income taxes in both the U.S. and several foreign jurisdictions. Significant judgments and estimates by management are required in determining the consolidated income tax expense assessment.

Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. In evaluating the Company’s ability to recover its deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, the Company begins with historical results and changes in accounting policies, and incorporates assumptions including the amount of future state, federal and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment and estimates by management about the forecasts of future taxable income and are consistent with the plans and estimates the Company uses to manage the underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income and/or loss. Valuation allowances are established when necessary to reduce deferred income tax assets to an amount more likely than not to be realized. SigmaTron and Wagz filed or are expected to file U.S. tax returns on a consolidated basis for periods during which Wagz was wholly owned. Therefore, a valuation allowance was previously established on the group’s U.S. deferred tax assets during fiscal year 2022. After the sale of Wagz, SigmaTron expects to file on a standalone basis and utilize its U.S. deferred tax assets with the exception of the capital loss on sale and certain foreign tax credits. The Company has established a valuation allowance of $7,258,454 on its U.S. capital loss and foreign tax credit carryforwards and a valuation allowance of $284,968 on certain foreign loss carryforwards as of July 31, 2023.

22


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note H - Significant Accounting Policies - Continued

Impairment of Long-Lived Assets - The Company reviews long-lived assets, including amortizable intangible assets, for impairment in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 360: Property, Plant and Equipment. Property, machinery and equipment and finite life intangible assets are reviewed whenever events or changes in circumstances occur that indicate possible impairment. If events or changes in circumstances occur that indicate possible impairment, the Company first performs an impairment review based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of its assets and liabilities. This analysis requires management judgment with respect to changes in technology, the continued success of product lines, and future volume, revenue and expense growth rates. If the carrying value exceeds the undiscounted cash flows, the Company records an impairment, if any, for the difference between the estimated fair value of the asset group and its carrying value. The Company further conducts annual reviews of its long-lived asset groups for possible impairment.

During the third quarter of fiscal 2023, the Company revised the financial outlook for the Pet Tech segment, resulting in lower projected sales and net income for future periods. The Company assessed the overall market acceptance of the then current Wagz product offerings after the holiday season and determined that this constituted a triggering event for the Company’s long-lived asset groups, primarily consisting of patents, trade names and certain fixed assets. The Company reviewed the undiscounted future cash flows for the identified long-lived asset group, and the results of the analysis indicated the carrying amount for the long-lived group was not expected to be recovered.

The fair value of the identified intangible assets was estimated using the relief from royalty method, which is a risk-adjusted discounted cash flow approach. The relief from royalty method values an intangible asset by estimating the royalties saved through ownership of the asset. The relief from royalty method requires identifying the future revenue that would be generated by the intangible asset, multiplying it by a royalty rate deemed to be avoided through ownership of the asset and discounting the projected royalty savings amounts back to the acquisition date using the internal rate of return.

The Company determined the fair value of the long-lived asset group was lower than its carrying value and recorded an intangible asset impairment charge of $9,527,773 during the third quarter of fiscal 2023. This non-cash charge was recorded to impairment of goodwill and intangible assets on the unaudited condensed consolidated statements of operations as of January 31, 2023. As of April 30, 2023 this non-cash charge had been reported under discontinued operations. See Note K – Intangible Assets and Note M – Discontinued Operations, for more information.

Goodwill - Goodwill represents the excess cost over fair value of the net assets of acquired businesses. The Company does not amortize goodwill and intangible assets that have indefinite lives. The Company performs an impairment assessment of goodwill and intangible assets with indefinite lives annually, or more frequently if triggering events occur, based on the estimated fair value of the related reporting unit or intangible asset. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. When performing its annual impairment assessment as of April 30, the Company evaluates the goodwill assigned to each of its reporting units for potential impairment by comparing the estimated fair value of the relevant reporting unit to the carrying value. The Company uses various Level 2 and Level 3

23


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note H - Significant Accounting Policies - Continued

valuation techniques to determine the fair value of its reporting units, including discounting estimated future cash flows based on a cash flow forecast prepared by the relevant reporting unit and market multiples of relevant public companies. If the fair value of a reporting unit is less than its carrying value, a goodwill impairment loss is recorded for the difference.

The Company observed during the third quarter of fiscal 2023, the overall lack of market acceptance of the then current Wagz product offerings during the holiday season and determined this constituted a triggering event. Accordingly, the Company performed a quantitative goodwill impairment test and estimated the fair value of the Pet Tech segment based on a combination of an income approach (estimates of future discounted cash flows), a market approach (market multiples for similar companies) and a cost approach. Significant unobservable inputs and assumptions inherent in the valuation methodologies, which represented Level 3 inputs, under the fair value hierarchy, were employed and included, but were not limited to, prospective financial information, terminal value assumptions, discount rates, and multiples from comparable publicly traded companies in the Pet Tech industry.

The cost approach is based on upon the concept of replacement cost as an indicator of value. Stated another way, this approach is premised on the assumption that a prudent investor would pay no more for an asset than the amount for which the asset could be replaced. The cost approach establishes value based on the cost reproducing or replacing the property, less depreciation from physical deterioration and functional obsolescence, if present and measurable.

During the third quarter of fiscal 2023, the Company determined its goodwill was fully impaired as the fair value was lower than the carrying value and recorded an impairment charge of $13,320,534. This non-cash charge was recorded to impairment of goodwill and intangible assets on the unaudited condensed consolidated statements of operations during the quarter ended January 31, 2023.

24


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note H - Significant Accounting Policies - Continued

New Accounting Standards:

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13, as amended by ASU 2019-04 and ASU 2019-05, that introduces a new forward-looking approach, based on expected losses, to estimate credit losses on certain types of financial instruments, including trade receivables. The estimate of expected credit losses will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. This ASU also expands the disclosure requirements to enable users of financial statements to understand the entity’s assumptions, models and methods for estimating expected credit losses. For smaller reporting companies, ASU 2016- 13 is effective for annual and interim reporting periods beginning after December 15, 2022, and the guidance is to be applied using the modified-retrospective approach. Earlier adoption is permitted. The Company adopted this ASU in the first quarter ended July 31, 2023 and it had no material impact on the consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions for a period of time to ease the potential burden in accounting for the transition from reference rates that are expected to be discontinued. Regulators and market participants in various jurisdictions have undertaken efforts to eliminate certain reference rates and introduce new reference rates that are based on a larger and more liquid population of observable transactions. The amendments in this update apply only to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. In January 2021, the FASB issued clarification on the scope of relief related to the reference rate reform. In December 2022, the FASB extended the period of time entities can use the reference rate reform relief guidance by two years which defers the sunset date from December 31, 2022 to December 31, 2024. The Company adopted this ASU in fiscal 2023 and it had no impact on its consolidated financial statements.

25


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note I – Leases

The Company leases office and storage space, vehicles and other equipment under non-cancellable operating leases with initial terms typically ranging from 1 to 5 years. At contract inception, the Company reviews the facts and circumstances of the arrangement to determine if the contract is or contains a lease. The Company follows the guidance in Topic 842 to evaluate whether the contract has an identified asset; if the Company has the right to obtain substantially all economic benefits from the asset; and if the Company has the right to direct the use of the underlying asset. When determining if a contract has an identified asset, the Company considers both explicit and implicit assets, and whether the supplier has the right to substitute the asset. When determining if the Company has the right to direct the use of an underlying asset, the Company considers if it has the right to direct how and for what purpose the asset is used throughout the period of use and if it controls the decision-making rights over the asset.

The Company’s lease terms may include options to extend or terminate the lease. The Company exercises judgment to determine the term of those leases when extension or termination options are present and includes such options in the calculation of the lease term when it is reasonably certain that it will exercise those options.

The Company has elected to include both lease and non-lease components in the determination of lease payments. Payments made to a lessor for items such as taxes, insurance, common area maintenance, or other costs commonly referred to as executory costs, are also included in lease payments if they are fixed. The fixed portion of these payments are included in the calculation of the lease liability, while any variable portion would be recognized as variable lease expenses, when incurred. Variable payments made to third parties for these, or similar costs, such as utilities, are not included in the calculation of lease payments.

At commencement, lease-related assets and liabilities are measured at the present value of future lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company exercises judgment in determining the incremental borrowing rate based on the information available when the lease commences to measure the present value of future payments.

Operating lease expense is recognized on a straight-line basis over the lease term. Finance lease cost includes amortization, which is recognized on a straight-line basis over the expected life of the leased asset, and interest expense, which is recognized following an effective interest rate method.

Operating leases are included in other assets, current operating lease obligations, and operating lease obligations (less current portion) on the Company’s Consolidated Balance Sheet. Finance leases are included in property, plant and equipment and current and long-term portion of finance lease obligations on the Company’s Consolidated Balance Sheet. Short term leases with an initial term of 12 months or less are not presented on the balance sheet with expense recognized as incurred.

26


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note I – Leases Continued

The following table presents lease assets and liabilities and their balance sheet classification:

July 31,

April 30,

Classification

2023

2023

Operating Leases:

Right-of-use Assets

Right-of-use assets

$

6,424,222 

$

7,225,423 

Operating lease current
liabilities

Current portion of operating lease
obligations

2,740,678 

2,908,213 

Operating lease noncurrent
liabilities

Operating lease obligations, less
current portion

4,111,504 

4,723,867 

Finance Leases:

Right-of-use Assets

Property, machinery and equipment

5,863,929 

5,294,097 

Finance lease current
liabilities

Current portion of finance lease
obligations

1,821,641 

1,523,259 

Finance lease noncurrent
liabilities

Finance lease obligations, less
current portion

2,902,042 

2,596,178 

The components of lease expense for the three month periods ended July 31, 2023 and 2022, are as follows:

Three Months

Three Months

Ended

Ended

Expense

July 31,

July 31,

Classification

2023

2022

Operating Leases:

Operating lease cost

Operating

895,469

623,811

Variable lease cost

Operating

56,900

54,815

Short term lease cost

Operating

2,250

2,250

Finance Leases:

Amortization of
right-of-use assets

Operating

640,847

571,103

Interest expense

Interest

119,686

63,614

Total

1,715,152

1,315,593

27


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note I – Leases Continued

The weighted average lease term and discount rates for the quarters ended July 31, 2023 and 2022, are as follows:

July 31,

July 31,

2023

2022

Operating Leases:

Weighted average remaining lease term (months)

34.57

43.42

Weighted average discount rate

3.4%

3.2%

Finance Leases:

Weighted average remaining lease term (months)

32.51

36.35

Weighted average discount rate

9.8%

9.5%

Future payments due under leases reconciled to lease liabilities are as follows:

Operating Leases

Finance Leases

For the remaining 9 months of the fiscal year ending April 30:

2024

$

2,219,127 

$

1,625,031 

For the fiscal years ending April 30:

2025

2,445,223 

1,985,274 

2026

1,920,820 

1,318,005 

2027

343,006 

488,060 

2028

74,382 

-

2029

75,870 

-

Thereafter

57,848 

-

Total undiscounted lease payments

7,136,276 

5,416,370 

Present value discount, less interest

284,094 

692,687 

Lease liability

$

6,852,182 

$

4,723,683 

28


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note I – Leases Continued

Supplemental disclosures of cash flow information related to leases for the three months ended July 31, 2023 and 2022 are as follows:

Three Months Ended

July 31,

July 31,

Other Information

2023

2022

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from finance leases

119,686 

63,614 

Operating cash flows from operating leases

61,121 

86,633 

Financing cash flows from finance leases

428,105 

353,258 

Supplemental non-cash information on lease liabilities arising from
obtaining right-of-use assets:

Right-of-use assets obtained in exchange for
new finance lease liabilities

1,032,351 

825,826 

Right-of-use assets obtained in exchange for
operating lease liabilities

1,531 

756,380 

Note J – Disposition

During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into the SPA with Wagz, Buyer and Anderton, pursuant to which the Company sold to Buyer 81% of Wagz common stock for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a Wagz Loan to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated with effect as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19% ownership of Wagz common stock and Buyer holds a majority 81% of Wagz common stock. See Note M – Discontinued Operations, for more information.

29


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note K – Intangible Assets

Intangible assets subject to amortization are summarized as of July 31, 2023 as follows:

July 31,2023

Gross

Carrying

Accumulated

Net Intangible

Amount

Amortization

Asset Balance

Spitfire:

Non-contractual customer relationship

4,690,000

3,462,385

1,227,615

Total

$

4,690,000

$

3,462,385

$

1,227,615

Intangible assets subject to amortization are summarized as of April 30, 2023 as follows:

April 30, 2023

Gross

Carrying

Accumulated

Impairment

Write Off

Net Intangible

Amount

Amortization

Amount

Amount

Asset Balance

Spitfire:

Non-contractual customer relationship

4,690,000

3,378,970

-

-

1,311,030

Wagz:

Trade name

1,230,000

68,380

813,960

347,660

-

Patents

9,730,000

586,313

8,713,813

429,874

-

Total

$

15,650,000

$

4,033,663

$

9,527,773

$

777,534

$

1,311,030

Estimated aggregate amortization expense for the Company’s intangible assets, which become fully amortized in 2028, for the remaining periods as of July 31, 2023, are as follows:

For the remaining 9 months of the fiscal year ending April 30:

2024

$

248,427

For the fiscal years ending April 30:

2025

324,702

2026

317,728

2027

310,900

2028

25,858

$

1,227,615

Amortization expense was $83,415 and $85,248 for the three month periods ended July 31, 2023 and July 31, 2022, respectively.

30


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note L – Segment and Geographic Area Information

The Company’s reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different technology and marketing strategies. Separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. For the Company, the CODM is the Company’s Chief Executive Officer.

The EMS reportable segment includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, the EMS segment provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. The EMS segment produces the Freedom Smart Dog Collar™ sold by the Pet Tech segment.

The Pet Tech reportable segment offered electronic products such as the Freedom Smart Dog Collar™, a wireless geo-mapped fence and wellness system, along with apparel and accessories. The majority of the Pet Tech Segment was sold, effective as of April 1, 2023. The results for the Pet Tech Segment are reported as discontinued operations for the three month period ended July 31, 2022.

The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note-A Description of the Business. The CODM allocates resources to and evaluates the performance of each operating segment based on operating income.

31


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note L – Segment and Geographic Area Information Continued

The tables below present information about the Company’s reportable segments for the three month periods ended July 31, 2023 and July 31, 2022.

Three Months Ended July 31, 2023

EMS

Pet Tech

Segment

Segment

Consolidated

Net sales

$

98,130,356

$

-

$

98,130,356

Operating income

2,808,415

-

2,808,415

Other income

18,627

Interest expense, net

(2,719,078)

Income before income taxes

$

107,964

Depreciation and amortization of property, machinery
and equipment

1,496,034

-

1,496,034

Amortization of intangible assets

83,415

-

83,415

Identifiable assets

$

259,835,108

$

-

$

259,835,108

Three Months Ended July 31, 2022

EMS

Pet Tech

Segment

Segment

Consolidated

Net sales (1)(2)

$

105,189,979

$

382,877

$

105,572,856

Operating income (loss)

5,047,378

(2,223,561)

2,823,817

Other income

35,816

Interest expense, net

(953,558)

Income before income taxes

$

1,906,075

Depreciation and amortization of property, machinery
and equipment

1,457,220

18,653

1,475,873

Amortization of intangible assets

85,248

150,514

235,762

Identifiable assets

$

292,367,580

$

23,685,666

$

316,053,246

(1)The EMS segment manufactures products sold to the Pet Tech segment. Related intersegment sales of $83,516 have been eliminated.

(2)The results for the Pet Tech Segment are reported as discontinued operations for the three month period ended July 31, 2022.

32


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note L – Segment and Geographic Area Information Continued

The following tables set forth net sales from continuing operations and tangible long-lived assets by geographic area where the Company operates. Tangible long-lived assets include property, machinery and equipment and operating lease assets.

Three Months Ended

July 31,

July 31,

2023

2022

Net sales:

U.S.

$

32,732,166

$

25,507,752

China

8,912,301

13,592,386

Vietnam

1,990,374

3,592,644

Mexico

54,495,515

62,497,197

Total net sales

$

98,130,356

$

105,189,979

July 31,

April 30,

2023

2023

Tangible long-lived assets, net:

U.S.

$

19,330,218

$

20,371,298

China

4,032,792

4,212,780

Mexico

18,210,501

17,574,899

Other

754,028

854,803

Total tangible long-lived assets, net

$

42,327,539

$

43,013,780

Note M – Discontinued Operations

During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into the SPA with Wagz, Buyer and Anderton, pursuant to which the Company sold to Buyer 81% of Wagz common stock for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a Wagz Loan to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated with effect as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19% ownership of Wagz common stock and Buyer holds a majority 81% of Wagz common stock.

In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the component of an entity meets the criteria in paragraph 205-20-45-10. In the period in which the component meets discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as

33


SigmaTron International, Inc.

July 31, 2023

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note M – Discontinued Operations Continued

components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.

Pet Tech Segment (Wagz Business)

The following amounts related to the Pet Tech Segment (Wagz Business) have been segregated from the Company’s continuing operations and are reported as discontinued operations:

Three months ended July 31,

2023

2022

Net Sales

$

-

$

382,877

Cost of products sold

-

275,062

Gross profit

-

107,815

Selling and administrative expenses

-

2,331,376

Operating loss

-

(2,223,561)

Loss before income taxes from discontinued operations

-

(2,223,561)

Income tax benefit

-

478,896

Loss from discontinued operations

$

-

$

(1,744,665)

34


SigmaTron International, Inc.

July 31, 2023

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.

In addition to historical financial information, this discussion of the business of SigmaTron International, Inc. (“SigmaTron” or collectively with its subsidiaries and foreign enterprises, the “Company”), its wholly-owned subsidiaries Standard Components de Mexico S.A., AbleMex, S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co., Ltd. and Wujiang SigmaTron Electronic Technology Co., Ltd., its international procurement office, SigmaTron International Inc. Taiwan Branch, and Wagz, Inc. (19 percent ownership as of July 31, 2023) (“Wagz”) and other Items in this Quarterly Report on Form 10-Q contain forward-looking statements concerning the Company’s business or results of operations. Words such as “continue,” “anticipate,” “will,” “expect,” “believe,” “plan,” and similar expressions identify forward-looking statements. These forward-looking statements are based on the current expectations of the Company. Because these forward-looking statements involve risks and uncertainties, the Company’s plans, actions and actual results could differ materially. Such statements should be evaluated in the context of the direct and indirect risks and uncertainties inherent in the Company’s business including, but not necessarily limited to, the Company’s continued dependence on certain significant customers; the continued market acceptance of products and services offered by the Company and its customers; pricing pressures from the Company’s customers, suppliers and the market; the activities of competitors, some of which may have greater financial or other resources than the Company; the variability of the Company’s operating results; the results of long-lived assets and goodwill impairment testing; the risks inherent in any merger, acquisition or business combination, including the ability to achieve the expected benefits of acquisitions as well as the expenses of acquisitions; the collectability of aged account receivables; the variability of the Company’s customers’ requirements; the impact of inflation on the Company’s operating results; the availability and cost of necessary components and materials; the impact acts of war may have to the supply chain; the ability of the Company and its customers to keep current with technological changes within its industries; regulatory compliance, including conflict minerals; the continued availability and sufficiency of the Company’s credit arrangements; the costs of borrowing under the Company’s senior and subordinated credit facilities, including under the rate indices that replaced LIBOR; increasing interest rates; the ability to meet the Company’s financial and restrictive covenants under its loan agreements; changes in U.S., Mexican, Chinese, Vietnamese or Taiwanese regulations affecting the Company’s business; the turmoil in the global economy and financial markets; public health crises, including COVID-19 and variants; the continued availability of scarce raw materials, exacerbated by global supply chain disruptions, necessary for the manufacture of products by the Company; the stability of the U.S., Mexican, Chinese, Vietnamese and Taiwanese economic, labor and political systems and conditions; global business disruption caused by the Russian invasion of Ukraine and related sanctions; currency exchange fluctuations; and the ability of the Company to manage its growth. These and other factors which may affect the Company’s future business and results of operations are identified throughout the Company’s Annual Report on Form 10-K, and as risk factors, may be detailed from time to time in the Company’s filings with the Securities and Exchange Commission. These statements speak as of the date of such filings, and the Company undertakes no obligation to update such statements in light of future events or otherwise unless otherwise required by law.


35


SigmaTron International, Inc.

July 31, 2023

Overview:

Until the sale described below, effective April 1, 2023, the Company operated in two reportable segments as an independent provider of electronic manufacturing services (“EMS”), and as a provider of products to the pet technology (“Pet Tech”) market. The majority of the Pet Tech Segment was sold, effective as of April 1, 2023, and following such date, the Company operates in one reportable segment, the EMS segment. The EMS segment includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. The Pet Tech segment offered electronic products such as the Freedom Smart Dog Collar ™, a wireless, geo-mapped fence, and wellness system, and apparel and accessories.

Except as otherwise noted, the description of the Company’s business below reflects its continuing operations. Refer to Note M - Discontinued Operations, to the consolidated financial statements for activity associated with discontinued operations.

The Company provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The Company has the ability to produce assemblies requiring mechanical as well as electronic capabilities. The products assembled by the Company are then incorporated into finished products sold in various industries, particularly industrial electronics, consumer electronics and medical/life sciences. In some instances, the Company manufactures and assembles the completed finished product for its customers.

In connection with the production of assembled products, the Company provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. The Company provides these manufacturing services through an international network of facilities located in the United States, Mexico, China, Vietnam and Taiwan.

The Company began its Pet Technology operations after the December 2021 acquisition of Wagz. During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023.

The Company relies on numerous third-party suppliers for components used in the Company’s production process. Certain of these components are available only from single-sources or a limited number of suppliers. In addition, a customer’s specifications may require the Company to obtain components from a single-source or a small number of suppliers. The loss of any such suppliers could have a material impact on the Company’s results of operations. Further, the Company could operate at a cost disadvantage compared to competitors who have greater direct buying power from suppliers. The Company does not enter into long-term purchase agreements with major or single-source suppliers. The Company believes that short-term purchase orders with its suppliers provides flexibility, given that the Company’s orders are based on the changing needs of its customers.

Sales can be an unreliable indicator of the Company’s financial performance. Sales levels can vary considerably among customers and products depending on the type of services (turnkey versus consignment) rendered by the Company and the demand by customers. Consignment orders require the Company to perform manufacturing services on components and other materials supplied by a

36


SigmaTron International, Inc.

July 31, 2023

customer, and the Company charges only for its labor, overhead and manufacturing costs, plus a profit. In the case of turnkey orders, the Company provides, in addition to manufacturing services, the components and other materials used in assembly. Turnkey contracts, in general, have a higher dollar volume of sales for each given assembly, owing to inclusion of the cost of components and other materials in net sales and cost of goods sold. Variations in the number of turnkey orders compared to consignment orders can lead to significant fluctuations in the Company’s revenue and gross margin levels. Consignment orders accounted for less than 1% of the Company’s revenues for the three month periods ended July 31, 2023 and July 31, 2022.

The Company’s international footprint provides our customers with flexibility within the Company to manufacture in China, Mexico, Vietnam or the U.S. We believe this strategy will continue to serve the Company well as its customers continuously evaluate their supply chain strategies.

The Company reported a pre-tax profit from continuing operations for the three months ended July 31, 2023 of $107,964. Pre-tax profit from continuing operations for the three months ended July 31, 2022 was $4,129,636. The Company recorded revenue of $98,130,356 and $105,189,979 in the three month periods ended July 31, 2023 and July 31, 2022, respectively.

The impact of inflation and the continuing global supply chain disruptions in the electronic component marketplace have continued to be challenging. The Company has certain customers that have lowered their demand, while others remain strong. The Company expects this uncertainty to remain short term as it expects customer requirements to pick up by third quarter for fiscal 2024. The Company has seen modest improvements to the supply chain challenges that it has experienced in at least the last 18 months, as a result of the slowing of the economy. The Company expects these challenges to continue to improve for fiscal 2024, based on what is known at this time.

37


SigmaTron International, Inc.

July 31, 2023

Results of Operations:

Consolidated Results

The following table sets forth the Company’s consolidated results of operations, including the percentage relationships of gross profit and expense items to net sales for the periods indicated:

Three Months Ended

July 31,

July 31,

2023

2022

Net sales

$

98,130,356

$

105,189,979

Cost of products sold

88,479,136

93,612,759

As a percent of net sales

90.2%

89.0%

Gross profit

9,651,220

11,577,220

As a percent of net sales

9.8%

11.0%

Selling and administrative expenses

6,842,805

6,529,842

As a percent of net sales

7.0%

6.2%

Operating income from continuing operations

2,808,415

5,047,378

Other income

18,627

35,816

Interest expense, net

(2,719,078)

(953,558)

Income before income taxes from continuing operations

107,964

4,129,636

Income tax benefit (expense)

154,135

(1,008,296)

Income from continuing operations

$

262,099

$

3,121,340

Discontinued operations:

Loss before taxes from discontinued operations

-

(2,223,561)

Tax benefit for discontinued operations

-

478,896

Net loss from discontinued operations

-

(1,744,665)

Net income

$

262,099

$

1,376,675

Net Sales

Net sales decreased $7,059,623, or -(6.7)%, to $98,130,356 for the three month period ended July 31, 2023, compared to $105,189,979 for the same period in the prior fiscal year. The Federal Reserve has raised interest rates several times during the last several quarters, which has negatively affected customer demand in the consumer electronics and industrial electronics markets, but has not had the same effect in the medical/life science market. As a result, the Company’s sales decreased for the three month period ended July 31, 2023, in the consumer electronics and industrial electronics markets, partially offset with an increase in net sales in the medical/life science market, compared to the same period in the prior fiscal year.

Costs of products sold

Cost of products sold decreased $5,133,623, or -(5.5)%, to $88,479,136 (90.2% of net sales) for the three month period ended July 31, 2023, compared to $93,612,759 (89.0% of net sales) for the same period in the prior fiscal year. The increase in cost of products sold as a percentage of sales is primarily due to higher labor costs and other manufacturing costs for the three month period ended

38


SigmaTron International, Inc.

July 31, 2023

July 31, 2023, than in the same period in the prior fiscal year, primarily due to continued inflationary pressures.

Gross profit margin

Gross profit margin was 9.8% of net sales, for the three month period ended July 31, 2023, compared to 11.0% for the same period in the prior fiscal year. The decrease in gross margins as a percentage of sales is primarily due to higher labor and other manufacturing costs during the three month period ended July 31, 2023, compared to the same period in the prior fiscal year.

Selling and administrative expenses

Selling and administrative expenses increased $312,963, or 4.8% to $6,842,805 (7.0% of net sales) for the three month period ended July 31, 2023, compared to $6,529,842 (6.2% of net sales) for the same period in the prior fiscal year. The increase in selling and administrative expenses is primarily due to an increase in accounting and legal professional fees, partially offset with a decrease in bonus expense.

Interest expense, net

Interest expense, net, increased to $2,719,078 for the three month period ended July 31, 2023, compared to $953,558 for the same period in the prior fiscal year. The increase relates to higher average debt levels as well as increased interest rates for the three month period ended July 31, 2023.

Income tax benefit/expense

Income tax expense decreased $1,162,431 to an income tax benefit of $154,135 for the three month period ended July 31, 2023, compared to an income tax expense of $1,008,296 for the same period in the prior fiscal year. The effective tax rate decreased to -142.76% for the three month period ended July 31, 2023, compared to 24.42% for the same period in the prior fiscal year. The decrease in income tax expense for the three month period ended July 31, 2023 compared to the same period in the previous year is due to decreased taxable earnings in the current quarter compared to the same period in the previous year. The decrease in effective tax rate is due to variations in income earned by jurisdiction.

Net income from continuing operations

Net income decreased $2,859,241, to $262,099 for the three month period ended July 31, 2023, compared to $3,121,340 for the same period in the prior fiscal year. The decreased net income primarily relates to lower sales, higher interest expense due to higher average debt levels and increased interest rates, partially offset by a decrease in bonus expense.

Net loss from discontinued operations

Net loss from discontinued operations was $1,744,665 for the three month period ended July 31, 2022. The net loss from discontinued operations consisted of operational losses from the Pet Tech segment.

39


SigmaTron International, Inc.

July 31, 2023

EMS Segment

The following table sets forth the Company’s results of operations for the EMS Segment, including the percentage relationships of gross profit and expense items to net sales for the periods indicated:

Three Months Ended

July 31,

July 31,

2023

2022

Net sales

$

98,130,356

$

105,189,979

Cost of products sold

88,479,136

93,612,759

As a percent of net sales

90.2%

89.0%

Gross profit

9,651,220

11,577,220

As a percent of net sales

9.8%

11.0%

Selling and administrative expenses

6,842,805

6,529,842

As a percent of net sales

7.0%

6.2%

Operating income

$

2,808,415

$

5,047,378

Net Sales

Net sales decreased $7,059,623, or -(6.7)%, to $98,130,356 for the three month period ended July 31, 2023, compared to $105,189,979 for the same period in the prior fiscal year. The Federal Reserve has raised interest rates several times during the current fiscal quarter, which has negatively affected customer demand in the consumer electronics and industrial electronics markets, but has not had the same effect in the medical/life science market. As a result, the Company’s sales decreased for the three month period ended July 31, 2023, in the consumer electronics and industrial electronics markets, partially offset with an increase in net sales in the medical/life science market, compared to the same period in the prior fiscal year.

Costs of products sold

Cost of products sold decreased $5,133,623, or -(5.5)%, to $88,479,136 (90.2% of net sales) for the three month period ended July 31, 2023, compared to $93,612,759 (89.0% of net sales) for the same period in the prior fiscal year. The increase in cost of products sold as a percentage of sales is primarily due to higher labor costs and other manufacturing costs for the three month period ended July 31, 2023, than in the same period in the prior fiscal year, primarily due to continued inflationary pressures.

Gross profit

Gross profit margin was 9.8% of net sales, for the three month period ended July 31, 2023, compared to 11.0% for the same period in the prior fiscal year. The decrease in gross margins as a percentage of sales is primarily due to higher labor and other manufacturing costs during the three month period ended July 31, 2023, compared to the same period in the prior fiscal year.

Selling and administrative expenses

Selling and administrative expenses increased $312,963, or 4.8% to $6,842,805 (7.0% of net sales) for the three month period ended July 31, 2023, compared to $6,529,842 (6.2% of net sales) for the same

40


SigmaTron International, Inc.

July 31, 2023

period in the prior fiscal year. The increase in selling and administrative expenses is primarily due to an increase in accounting and legal professional fees, partially offset with a decrease in bonus expense.

Operating income

Operating income decreased $2,238,963, to $2,808,415 (2.9% of net sales) for the three month period ended July 31, 2023, compared to operating income of $5,047,378 (4.8% of net sales) for the same period in the prior fiscal year. The decrease was primarily due to lower sales and higher labor and other manufacturing costs.

Pet Tech Segment

The Company sold a majority of its interest in Wagz April 28, 2023, effective as of April 1, 2023. The Company still owns 19 percent of Wagz common stock as a passive investment as of July 31, 2023. The activity for fiscal 2023 has been classified as discontinued operations in the Consolidated Statements of Operations.

The following table sets forth the results of operations for the Pet Tech Segment, including the percentage relationships of gross profit and expense items to net sales for the periods indicated:

Three Months Ended

July 31,

July 31,

2023

2022

Net sales

$

-

$

382,877

Cost of products sold

-

275,062

As a percent of net sales

-

71.8%

Gross profit

-

107,815

As a percent of net sales

-

28.2%

Selling and administrative expenses

-

2,331,376

As a percent of net sales

-

608.9%

Operating loss

$

-

$

(2,223,561)

Net sales

There were no net sales for the three month period ended July 31, 2023 compared to $382,877 for the same period in the prior fiscal year. Sales for the prior period were primarily comprised of hardware and accessories, as well as recurring subscription revenue.

Cost of products sold

There were no cost of products sold for the three month period ended July 31, 2023, compared to $275,062 (71.8% of net sales) for the same period in the prior fiscal year.

Gross profit margin

There was no gross profit margin of net sales for the three month period ended July 31, 2023 compared to gross profit margin of 28.2% for the same period in the prior fiscal year.‌

41


SigmaTron International, Inc.

July 31, 2023

Selling and administrative expenses

There were no selling and administrative expenses for the three month period ended July 31, 2023, compared to $2,331,376 for the same period in the prior fiscal year. Selling and administrative costs were primarily comprised of research and development costs for new products expected to have launched in fiscal 2024, selling and marketing expenses, as well as general and administrative expenses.

Operating loss

There was no operating loss the three month period ended July 31, 2023, compared to $2,223,561 for the same period in the prior fiscal year.

Liquidity and Capital Resources:

Operating Activities.

Cash flow provided by operating activities from continuing operations was $7,750,014 for the three months ended July 31, 2023, compared to cash flow used in operating activities of $16,669,235 for the same period in the prior fiscal year. Cash flow provided by operating activities from continuing operations was primarily the result of a decrease in inventory in the amount of $7,092,926 and a decrease in accounts receivable in the amount of $2,058,165. Cash flow from operating activities from continuing operations was offset by a decrease in deferred revenue in the amount of $2,520,928. The decrease in inventory is the result of improvement in the component marketplace which has allowed the Company to complete assemblies for shipping. The decrease in accounts receivable is a result of lower accounts receivable balances due to lower volumes during the first quarter, as compared to the same period in the prior year.

Cash flow used in operating activities from continuing operations was $16,669,235 for the three months ended July 31, 2022. Cash flow used in operating activities was primarily the result of an increase in both inventory and accounts receivable in the amount of $11,397,902 and $10,837,157, respectively. Cash flow from operating activities was offset by an increase in deferred revenue in the amount of $3,085,492.

Investing Activities.

Cash used in investing activities from continuing operations was $621,929 for the three months ended July 31, 2023. During the first three months of fiscal year 2024, the Company purchased $621,929 in machinery and equipment to be used in the ordinary course of business. The Company anticipates future purchases of machinery and equipment will be funded by lease transactions. However, there is no assurance that the Company will be able to obtain funding for leases at acceptable terms, if at all, in the future.

Cash used in investing activities from continuing operations was $313,934 for the three months ended July 31, 2022. During the first three months of fiscal year 2023, the Company purchased $313,934 in machinery and equipment used in the ordinary course of business.

42


SigmaTron International, Inc.

July 31, 2023

Financing Activities.

Cash used in financing activities from continuing operations of $6,292,323 for the first three months ended July 31, 2023, was primarily the result of net payments under the line of credit and term loan agreement.

Cash provided by financing activities from continuing operations of $19,887,738 for the first three months ended July 31, 2022, was primarily the result of net borrowings under the line of credit.

Liquidity from Discontinued Operations

During the first three months ended July 31, 2022 cash used in discontinued operations from operating activities was $1,457,558, primarily related to Pet Tech Segment operations. During the first three months ended July 31, 2022, cash used in investing activities primarily for capital expenditures was $55,481.

Financing Summary.

Notes Payable – Secured lenders

On January 29, 2021, the Company entered into a Credit Agreement (the “JPM Agreement”) with JPMorgan Chase Bank, N.A. (“Lender” or “JPM”), pursuant to which Lender provided the Company with a secured credit facility consisting of a revolving loan facility and a term loan facility (collectively, the “Facility”).

On July 18, 2022, SigmaTron, Wagz and Lender amended and restated the JPM Agreement by entering into an Amended and Restated Credit Agreement (as so amended and restated, the “JPM Credit Agreement”). The Facility, as amended, allows the Company to borrow on a revolving basis up to the lesser of (i) $70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender (the “Revolving Commitment”). The maturity date of the Facility is July 18, 2027. Deferred financing costs of $238,576 and $332,139 were capitalized during the three month period ended July 31, 2023 and during the fiscal year ended April 30, 2023, respectively, which are amortized over the term of the JPM Credit Agreement. As of July 31, 2023, there was $45,407,584 outstanding and $12,468,259 of unused availability under the revolving loan facility compared to an outstanding balance of $51,134,699 and $11,539,183 of unused availability at April 30, 2023. As of July 31, 2023 and April 30, 2023, the unamortized amount offset against outstanding debt was $763,478 and $572,191, respectively.

Under the JPM Credit Agreement, a minimum Fixed Charge Coverage Ratio (“FCCR”) financial covenant of 1.10x is applicable only during an FCCR trigger period which occurs when (a) commencing on the Effective Date (as defined in the JPM Credit Agreement) and ending when the Term Loan Obligations (as defined in the JPM Credit Agreement) have been paid in full and (b) following the payment in full of the Term Loan Obligations, (i) an event of default (as defined in the JPM Credit Agreement) has occurred and is continuing, and Lender has elected to impose a FCCR trigger period upon notice to the Company or (ii) availability falls below the greater of (y) 10% of the Revolving Commitment and (z) the outstanding principal amount of the term loans. In addition, prior to the amendment to the JPM Credit Agreement pursuant to the JPM Waiver (as discussed below under “Waiver, Consent and Amendment to Credit Agreements”), the JPM Credit Agreement imposed a financial covenant that required the Company to maintain a leverage ratio of Total Debt to EBITDA

43


SigmaTron International, Inc.

July 31, 2023

(each as defined in the JPM Credit Agreement) for any twelve month period ending on the last day of a fiscal quarter through the maturity of the revolving Facility not to exceed a certain amount, which ratio (a) ranged from 5.00-to-1 for fiscal quarters beginning with the fiscal quarter ending on January 31, 2023 to 3.00-to-1 for the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio (as defined in the JPM Credit Agreement) as of the end of the applicable fiscal quarter is less than or equal to 1.50-to-1) and (b) ranged from 5.50-to-1 for the fiscal quarter ending on January 31, 2023 to 4.00-to-1 for the fiscal quarters beginning with the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio as of the end of the applicable fiscal quarter is greater than 1.50-to-1).

In addition, the JPM Credit Agreement imposes a cash dominion period if there is an event of default or if availability is less than 10% of the Revolving Commitment, and such requirement continues until there is no event of default and availability is greater than 10% of the Revolving Commitment, in each case for 30 consecutive days. Based on this criteria, the total debt balances for the Facility must be classified as a current liability on the Consolidated Balance Sheet as of July 31, 2023 and April 30, 2023.

In connection with the entry into the JPM Credit Agreement, Lender and TCW Asset Management Company LLC, as administrative agent under the Term Loan Agreement (as defined below), entered into the Intercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”), to set forth and govern the lenders’ respective lien priorities, rights and remedies under the JPM Credit Agreement and the Term Loan Agreement.

The Facility under the JPM Credit Agreement is secured by: (a) a first priority security interest in SigmaTron’s and Wagz’s (i) accounts receivable and inventory (excluding Term Priority Mexican Inventory (as defined in the ICA) and certain inventory in transit, (ii) deposit accounts, (iii) proceeds of business interruption insurance that constitute ABL BI Insurance Share (as defined in the ICA), (iv) certain other property, including payment intangibles, instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all proceeds of the foregoing, in each case, now owned or hereafter acquired (collectively, the “ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) the equity interests of SigmaTron’s foreign subsidiaries (unless such a pledge is requested by Lender).

On July 18, 2022, SigmaTron, Wagz and TCW Asset Management Company LLC, as administrative agent (the “Agent), and other Lenders party thereto (collectively, “TCW Lenders,” together with the Agent, “TCW”) entered into a Credit Agreement (the “Term Loan Agreement”) pursuant to which TCW made a term loan to the Company in the principal amount of $40,000,000 (the “TCW Term Loan”). The TCW Term Loan bears interest at a rate per annum based on SOFR, plus the Applicable Margin of 7.50% (each as defined in the Term Loan Agreement). The TCW Term Loan has a SOFR floor of 1.00%. The maturity date of the TCW Term Loan is July 18, 2027. The amount outstanding as of July 31, 2023, was $39,583,301 compared to an outstanding balance of $39,833,301 at April 30, 2023. Deferred financing costs of $141,366 and $1,233,894 were capitalized during the three month period ended July 31, 2023 and fiscal year ended April 30, 2023, respectively. As of July 31, 2023 and April 30, 2023, the unamortized amount offset against outstanding debt was $1,108,277 and $1,036,367, respectively.

The Term Loan Agreement imposes financial covenants, including covenants requiring the Company to maintain a minimum Fixed Charge Coverage Ratio (as defined in the Term Loan Agreement) of 1.10-to-1 and maintain the same leverage ratio of Total Debt to EBITDA as described above under the

44


SigmaTron International, Inc.

July 31, 2023

JPM Credit Agreement. The Company is required to make quarterly repayments of the principal amount of the TCW Term Loan in amounts equal to $250,000 per fiscal quarter for the quarters beginning October 31, 2022 and $500,000 per fiscal quarter for quarters beginning October 31, 2024. The Term Loan Agreement also requires mandatory annual repayments equal to 50% of Excess Cash Flow (as defined in the Term Loan Agreement).

The TCW Term Loan is secured by: (a) a first priority security interest in all property of SigmaTron and Wagz that does not constitute ABL Priority Collateral, which includes: (i) SigmaTron’s and Wagz’s real estate other than SigmaTron’s Del Rio, Texas, warehouses, (ii) SigmaTron’s and Wagz’s machinery, equipment and fixtures (but excluding ABL Priority Equipment (as defined in the ICA)), (iii) the Term Priority Mexican Inventory (as defined in the ICA), (iv) SigmaTron’s stock in its direct and indirect subsidiaries, (v) SigmaTron’s and Wagz’s general intangibles (excluding any that constitute ABL Priority Collateral), goodwill and intellectual property, (vi) the proceeds of business interruption insurance that constitute Term BI Insurance Share (as defined in the ICA), (vii) tax refunds, and (viii) all proceeds thereof, in each case, now owned or hereafter acquired (collectively, the “Term Priority Collateral”); and (b) a second priority security interest in all collateral that constitutes ABL Priority Collateral. Also, SigmaTron’s three Mexican subsidiaries pledged all of their assets as security for the TCW Term Loan.

Waiver, Consent and Amendment to Credit Agreements

On March 2, 2023, the Company received notices of default from both JPM and TCW. The Notices indicated the occurrence of certain events of default under the JPM Credit Agreement and the Term Loan Agreement (together with the JPM Credit Agreement the “Credit Agreements”). In addition, the Company received a delinquency notification letter from Nasdaq indicating that the Company was not in compliance with the continued listing requirements of Nasdaq for failing to timely file the Companys Form 10-Q for the fiscal quarter ended January 31, 2023. This notification also constituted a default under the Credit Agreements. The delinquency was remedied on May 19, 2023.

The JPM Notice indicated that the Lender was informed of the occurrence of events of defaults and the continuation thereof under the JPM Credit Agreement as a result of the Company’s failure to maintain a FCCR for the twelve month period ended January 31, 2023 of at least 1.10x as required under the JPM Credit Agreement (the “JPM Covenant Defaults”).

The TCW Notice indicated that Agent and TCW Lenders were informed of the occurrence of events of default and the continuation thereof under the Term Loan Agreement (described below) as a result of the Company permitting the Total Debt to EBITDA Ratio for the twelve month period ended on January 31, 2023 to be greater than 5.00:1.00 in violation of the Term Loan Agreement and the Company’s failure to maintain FCCR as required under the JPM Credit Agreement (the “TCW Covenant Defaults” and together with the JPM Covenant Defaults, the “Defaults”).

As a result of the Defaults, the Company was not in compliance with its financial covenants under the Credit Agreements as of January 31, 2023. Due to the Notices received on March 2, 2023, from each of JPM and TCW, the total debt balances for both the Facility and the TCW Term Loan had been classified as a current liability on the Condensed Consolidated Balance Sheet as of January 31, 2023.

On April 28, 2023, the Company entered into (i) a Waiver, Consent and Amendment No. 1 to the JPM Credit Agreement (“JPM Waiver”) with Wagz and JPM, as lender, which waived certain events of default under and amended certain terms of the JPM Credit Agreement and (ii) a Waiver, Consent

45


SigmaTron International, Inc.

July 31, 2023

and Amendment No. 1 to the Credit Agreement (“TCW Waiver”) with Wagz and TCW (collectively with JPM, the “Lender Parties”), which waived certain events of default under and amended certain terms of the Credit Agreements. The Company was in compliance with its revised financial covenants under the Credit Agreements as of July 31, 2023.

Pursuant to the Waivers, the Company has agreed, among other things, to (i) if requested by the Agent, effect a corporate restructuring that would create a new holding company structure to own all of the Companys stock through a merger pursuant to Section 251(g) of the General Corporation Law of the State of Delaware, after which the holding company would continue as the public company, become a guarantor under the Credit Agreements and pledge to the Lender Parties all of the equity of the Company (the “Corporate Restructuring”), (ii) engage a financial advisor to review certain of the Companys financial reporting to JPM and the Agent and participate in weekly conference calls with the advisor, JPM and the Agent to discuss and provide updates on the Companys liquidity and operations, (iii) extend the Wagz Loan, (iv) pay to JPM an amendment fee in the amount of $70,000, paid in cash, and (v) pay to the TCW Lenders an amendment fee of $395,000 and a default rate fee of $188,301, both of which were paid in kind by being added to the principal of the TCW Term Loan.

The Waivers also amended the Credit Agreements to, among other things, (x) require that the Company maintain a minimum of $2.5 million in revolver availability under the JPM Credit Agreement, (y) modify the definition of EBITDA to allow adjustments to account for Wagz operating losses, impairment charges relating to the write-down of the Wagz business, the Wagz Loan and net assets of the Company and Wagz, and expenses relating to the Waivers, the Wagz sale and SPA, and (z) modify the existing Total Debt to EBITDA Ratios (as defined in the Credit Agreements) as follows:

Fiscal Quarter

Total Debt to EBITDA Ratio* (as amended)

Total Debt to EBITDA Ratio* (prior to amendment)

October 31,2023

4.50:1.0

4.25:1.0

January 31, 2024

4.50:1.0

4.00:1.0

April 30, 2024

4.50:1.0

4.00:1.0

July 31, 2024

4.25:1.0

3.75:1.0

October 31, 2024

4.00:1.0

3.75:1.0

* Assumes the Term Loan Borrowing Base Coverage Ratio (as defined in the Credit Agreements) is less than or equal to 1.50:1.0.

In addition, pursuant to the TCW Waiver, if the Total Debt to EBITDA Ratio for the trailing twelve month period as of the end of the third quarter of fiscal 2023 exceeds the ratios that were in effect prior to the amendment (as set forth in the far right column of the table above) for a fiscal quarter during the PIK Period (defined in the Term Loan Agreement), then the Applicable Margin under the Term Loan Agreement in respect of the outstanding TCW Term Loan would increase by an amount equal to 1.0% per annum for the fiscal quarter, with such interest being paid in kind. Furthermore, the JPM Waiver modified the definition of Applicable Margin from a fixed amount equal to 2.00% to an amount that varies from 2.00% (for revolver availability greater than or equal to $20.0 million), to 2.50% (for revolver availability greater than or equal to $10.0 million), to 3.00% (for revolver availability less than $10.0 million), and fixed the Applicable Margin at 3.00% for six months starting April 1, 2023. The Company was in compliance with its revised financial covenants under the Credit Agreements as of July 31, 2023.

46


SigmaTron International, Inc.

July 31, 2023

In exchange for such agreements, the Lender Parties waived all of the existing events of default under the Credit Agreements through March 31, 2023, consented to the sale of Wagz and released Wagz and its property and the Companys 81% interest in Wagz that was sold to Buyer (as disclosed above) from the lien of the Lender Parties.

In connection with the Waivers, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023.

On June 15, 2023, the Company entered into (i) Amendment No. 2 to the Credit Agreement (the “JPM Amendment No. 2”) by and among the Company and Lender, with respect to the JPM Credit Agreement and (ii) Amendment No. 2 to the Credit Agreement (“TCW Amendment No. 2”) by and among the Company and TCW with respect to the Term Loan Agreement. The JPM Amendment No. 2 and TCW Amendment No. 2 (together, the “Amendments”) amended the Credit Agreements to extend the date, from May 31, 2023 to July 31, 2023, after which the Agent may request that the Company effect the Corporate Restructuring.

On March 15, 2019, the Company’s wholly-owned foreign enterprise, Wujiang SigmaTron Electronic Technology Co., Ltd., entered into a credit facility with China Construction Bank. On January 26, 2021, the agreement was amended and expired in accordance with its terms on January 6, 2022. On January 17, 2022, the agreement was renewed, and expired in accordance with its terms on December 23, 2022. On February 17, 2023, the agreement was renewed, and is scheduled to expire on February 7, 2024. Under the agreement Wujiang SigmaTron Electronic Technology Co., Ltd. can borrow up to 10,000,000 Renminbi, approximately $1,400,000 as of July 31, 2023, and the facility is collateralized by Wujiang SigmaTron Electronics Co., Ltd.’s manufacturing building. Interest is payable monthly and the facility bears a fixed interest rate of 3.35% per annum. There was no outstanding balance under the facility at July 31, 2023 and April 30, 2023.

Notes Payable – Buildings

The Company entered into a mortgage agreement on March 3, 2020, in the amount of $556,000, with The Bank and Trust SSB to finance the purchase of the property that serves as the Company’s warehousing and distribution center in Del Rio, Texas. The note requires the Company to pay monthly installment payments in the amount of $6,103. Interest accrues at a fixed rate of 5.75% per year until March 3, 2025, and adjusts thereafter, on an annual basis, equal to 1.0% over the Prime Rate as published by The Wall Street Journal. The note is payable over a 120 month period. The outstanding balance was $404,771 and $417,143 at July 31, 2023 and April 30, 2023, respectively.

Notes Payable – Equipment

The Company routinely entered into secured note agreements with Engencap Fin S.A. DE C.V. to finance the purchase of equipment. The terms of the outstanding secured note agreement, which had a fixed interest rate of 8.00% per annum, matured on May 1, 2023, with a final quarterly installment payment of $9,310.

The Company routinely enters into secured note agreements with FGI Equipment Finance LLC to finance the purchase of equipment. The terms of the outstanding secured note agreements mature from March 2025 through August 2028, with quarterly installment payments ranging from $10,723 to $69,439 and a fixed interest rate ranging from 8.25% to 11.75% per annum.

47


SigmaTron International, Inc.

July 31, 2023

Finance Lease Obligations

The Company enters into various finance lease agreements. The terms of the outstanding lease agreements mature through April 1, 2027, with monthly installment payments ranging from $2,874 to $33,706 and a fixed interest rate ranging from 7.09% to 12.73% per annum.

Other

The Company provides funds for salaries, wages, overhead and capital expenditure items as necessary to operate its wholly-owned Mexican, Vietnamese and Chinese subsidiaries and the Taiwan IPO. The Company provides funding in U.S. Dollars, which are exchanged for Pesos, Dong, Renminbi, and New Taiwan dollars. The fluctuation of currencies from time to time, without an equal or greater increase in inflation, could have a material impact on the financial results of the Company. The impact of currency fluctuations for the three month period ended July 31, 2023, resulted in net foreign currency transaction losses of $275,970 compared to net foreign currency losses of $243,316 for the same period in the prior year. During the three months of fiscal year 2024, the Company paid approximately $15,080,000 to its foreign subsidiaries for manufacturing services. All intercompany balances have been eliminated upon consolidation.

The Company has not changed its plans to indefinitely reinvest the earnings of the Company’s foreign subsidiaries. The cumulative amount of unremitted earnings for which U.S. income taxes have not been recorded is $13,878,000 as of July 31, 2023.

The Company anticipates that its credit facilities, expected future cash flow from operations and leasing resources are adequate to meet its working capital requirements and fund capital expenditures for the next 12 months. However, in the event customers delay orders or future payments are not made timely, the Company desires to expand its operations, its business grows more rapidly than expected, or the current economic climate deteriorates, additional financing resources may be necessary. There is no assurance that the Company will be able to obtain equity or debt financing at acceptable terms, or at all, in the future.  There is no assurance that the Company will be able to retain or renew its credit agreements in the future, or that any retention or renewal will be on the same terms as currently exist.

The impact of inflation and the continuing global supply chain disruptions in the electronic component marketplace have continued to be challenging. The Company has certain customers that have lowered their demand, while others remain strong. The Company expects this uncertainty to remain short term as it expects customer requirements to pick up by third quarter for fiscal 2024. The Company has seen modest improvements to the supply chain challenges that it has experienced in at least the last 18 months, as a result of the slowing of the economy. The Company expects these challenges to continue to improve for fiscal 2024, based on what is known at this time.

 

Item 3.Quantitative and Qualitative Disclosures About Market Risks.

As a smaller reporting company, as defined in Item 10(f)(1) of Regulation S-K under the Exchange Act, the Company is not required to provide the information required by this item.

Item 4.Controls and Procedures.

Disclosure Controls:

48


SigmaTron International, Inc.

July 31, 2023

The Company’s management, including its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of its disclosure controls and procedures (as defined under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rules 13a-15(e) and 15(d)-15(e) thereunder) as of July 31, 2023. The Company’s disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives and its Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective at the reasonable assurance level as of July 31, 2023.

Internal Controls:

There has been no change in the Company’s internal control over financial reporting during the three months ended July 31, 2023, that has materially affected or is reasonably likely to materially affect its internal control over financial reporting. The Company’s internal controls over financial reporting are designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with U.S. GAAP.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time the Company is involved in legal proceedings, claims, or investigations that are incidental to the Company’s business. In future periods, the Company could be subjected to cash cost or non-cash charges to earnings if any of these matters are resolved on unfavorable terms. However, although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including management’s assessment of the merits of any particular claim, the Company does not expect these legal proceedings or claims will have any material adverse impact on its future consolidated financial position, results of operations or cash flows.

Item 1A. Risk Factors.

As a smaller reporting company, as defined in Item 10(f)(1) of Regulation S-K under the Exchange Act, the Company is not required to provide the information required by this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None beyond what was previously disclosed.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

 

49


SigmaTron International, Inc.

July 31, 2023

Item 6.Exhibits.

31.1

Certification of Principal Executive Officer of the Company Pursuant to Rule 13a-14(a) under the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).

31.2

Certification of Principal Financial Officer of the Company Pursuant to Rule 13a-14(a) under the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).

32.1

Certification by the Principal Executive Officer of SigmaTron International, Inc. Pursuant to Rule 13a-14(b) under the Exchange Act and Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).

32.2

Certification by the Principal Financial Officer of SigmaTron International, Inc. Pursuant to Rule 13a-14(b) under the Exchange Act and Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).

101.INS

Inline XBRL Instance Document (the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document)

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)

 

50


SigmaTron International, Inc.

July 31, 2023

SIGNATURES:

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SIGMATRON INTERNATIONAL, INC.

/s/ Gary R. Fairhead

September 12, 2023

Gary R. Fairhead

Date

CEO (Principal Executive Officer)

/s/ James J. Reiman

September 12, 2023

 

 

James J. Reiman

Date

Chief Financial Officer, Secretary and Treasurer

(Principal Financial Officer and Principal

Accounting Officer)

 

51